Literature DB >> 19357305

Second-generation HIV microbicides: continued development of griffithsin.

Larry Zeitlin1, Michael Pauly, Kevin J Whaley.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19357305      PMCID： PMC2669335          DOI： 10.1073/pnas.0902239106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

Review 1.  Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices.

Authors:  T R Moench; T Chipato; N S Padian
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

Review 2.  Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update.

Authors:  Sheryl L Lard-Whiteford; Dorota Matecka; Julian J O'Rear; Ita S Yuen; Charles Litterst; Patricia Reichelderfer
Journal:  J Acquir Immune Defic Syndr       Date:  2004-05-01       Impact factor: 3.731

Review 3.  Magnifection--a new platform for expressing recombinant vaccines in plants.

Authors:  Y Gleba; V Klimyuk; S Marillonnet
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

4.  Monoclonal antibodies from plants: a new speed record.

Authors:  Andrew Hiatt; Michael Pauly
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

5.  Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.

Authors:  Toshiyuki Mori; Barry R O'Keefe; Raymond C Sowder; Scott Bringans; Roberta Gardella; Shannon Berg; Pamela Cochran; Jim A Turpin; Robert W Buckheit; James B McMahon; Michael R Boyd
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

6.  Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.

Authors:  P Emau; B Tian; B R O'keefe; T Mori; J B McMahon; K E Palmer; Y Jiang; G Bekele; C C Tsai
Journal:  J Med Primatol       Date:  2007-08       Impact factor: 0.667

7.  Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus.

Authors:  Margaret R H Nusbaum; Robin R Wallace; Lisa M Slatt; Elin C Kondrad
Journal:  J Am Osteopath Assoc       Date:  2004-12

8.  Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.

Authors:  Carol Lackman-Smith; Clay Osterling; Katherine Luckenbaugh; Marie Mankowski; Beth Snyder; Gareth Lewis; Jeremy Paull; Albert Profy; Roger G Ptak; Robert W Buckheit; Karen M Watson; James E Cummins; Brigitte E Sanders-Beer
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

9.  Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.

Authors:  A A McCormick; S Reddy; S J Reinl; T I Cameron; D K Czerwinkski; F Vojdani; K M Hanley; S J Garger; E L White; J Novak; J Barrett; R B Holtz; D Tusé; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-21       Impact factor: 11.205

10.  Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig.

Authors:  Alison A McCormick; Stephen J Reinl; Terri I Cameron; Fakhrieh Vojdani; Michele Fronefield; Ronald Levy; Daniel Tusé
Journal:  J Immunol Methods       Date:  2003-07       Impact factor: 2.303
View more
  13 in total

1.  The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.

Authors:  Jie Xue; Bart Hoorelbeke; Ioannis Kagiampakis; Borries Demeler; Jan Balzarini; Patricia J Liwang
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

2.  The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.

Authors:  Jie Xue; Yongguang Gao; Bart Hoorelbeke; Ioannis Kagiampakis; Bo Zhao; Borries Demeler; Jan Balzarini; Patricia J Liwang
Journal:  Mol Pharm       Date:  2012-08-21       Impact factor: 4.939

3.  Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.

Authors:  Kevin M Tyo; Amanda B Lasnik; Longyun Zhang; Mohamed Mahmoud; Alfred B Jenson; Joshua L Fuqua; Kenneth E Palmer; Jill M Steinbach-Rankins
Journal:  J Control Release       Date:  2020-02-05       Impact factor: 9.776

4.  Grifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, Griffithsin.

Authors:  Ewa D Micewicz; Amy L Cole; Chun-Ling Jung; Hai Luong; Martin L Phillips; Pratikhya Pratikhya; Shantanu Sharma; Alan J Waring; Alexander M Cole; Piotr Ruchala
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

5.  sCD4-17b bifunctional protein: extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates.

Authors:  Laurel A Lagenaur; Vadim A Villarroel; Virgilio Bundoc; Barna Dey; Edward A Berger
Journal:  Retrovirology       Date:  2010-02-16       Impact factor: 4.602

6.  HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity.

Authors:  Nobuyuki Matoba; Adam S Husk; Brian W Barnett; Michelle M Pickel; Charles J Arntzen; David C Montefiori; Atsushi Takahashi; Kazunobu Tanno; Satoshi Omura; Huyen Cao; Jason P Mooney; Carl V Hanson; Haruo Tanaka
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

7.  A perspective on progress and gaps in HIV prevention science.

Authors:  Patrick F Kiser; Pedro M M Mesquita; Betsy C Herold
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11       Impact factor: 2.205

8.  Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity.

Authors:  Tinoush Moulaei; Shilpa R Shenoy; Barbara Giomarelli; Cheryl Thomas; James B McMahon; Zbigniew Dauter; Barry R O'Keefe; Alexander Wlodawer
Journal:  Structure       Date:  2010-09-08       Impact factor: 5.006

9.  Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus.

Authors:  Tinoush Moulaei; Kabamba B Alexandre; Shilpa R Shenoy; Joel R Meyerson; Lauren Rh Krumpe; Brian Constantine; Jennifer Wilson; Robert W Buckheit; James B McMahon; Sriram Subramaniam; Alexander Wlodawer; Barry R O'Keefe
Journal:  Retrovirology       Date:  2015-01-23       Impact factor: 4.602

Review 10.  Bulk production of the antiviral lectin griffithsin.

Authors:  Joshua L Fuqua; Krystal Hamorsky; Guruatma Khalsa; Nobuyuki Matoba; Kenneth E Palmer
Journal:  Plant Biotechnol J       Date:  2015-07-14       Impact factor: 9.803
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.